School of Health Systems and Public Health, University of Pretoria Faculty of Health Sciences, Pretoria, South Africa
School of Health Systems and Public Health, University of Pretoria Faculty of Health Sciences, Pretoria, South Africa.
BMJ Open. 2022 May 2;12(5):e056140. doi: 10.1136/bmjopen-2021-056140.
Evidence shows that women in sub-Saharan Africa have high rates of cervical cancer (CC) mortality compared with women in high-income countries. Effective screening programmes have significantly reduced the burden of CC in high-income countries. Self-sampling for human papillomavirus testing (HPVSS) has been reported to increase the participation and engagement of women in CC screening. Before HPVSS can be introduced for CC screening there is a need to establish its acceptability among end-users to ensure the increase in CC screening rates. Here, we outline a protocol for a scoping review aimed at mapping literature on the use and acceptability of HPVSS for screening CC in sub-Saharan Africa to reveal gaps to guide future research and practice.
The scoping review protocol was developed according to Arksey and O'Malley and Levac , and guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews. We will search Scopus, PubMed, Medline Ovid, Cochrane and Web of Science databases for evidence on the use and acceptability of HPVSS published between January 2011 and July 2021. We will also search grey literature in the form of dissertations/theses, conference proceedings, websites of international organisations such as the WHO, and relevant government reports reporting evidence on HPVSS programmes for screening CC among women in sub-Saharan Africa.
No ethical approval is needed for the study as it will not include animals or human participants. The results of the proposed scoping review will be disseminated electronically in peer-reviewed journals, in print and through conference presentations.
有证据表明，与高收入国家的女性相比，撒哈拉以南非洲的女性宫颈癌（CC）死亡率较高。有效的筛查计划显著降低了高收入国家的 CC 负担。人乳头瘤病毒自我采样检测（HPVSS）已被报道可提高女性参与 CC 筛查的积极性和参与度。在将 HPVSS 引入 CC 筛查之前，需要在最终用户中确定其可接受性，以确保 CC 筛查率的提高。在这里，我们概述了一项范围综述的方案，旨在绘制撒哈拉以南非洲使用 HPVSS 筛查 CC 的文献，并确定其使用和可接受性的差距，以指导未来的研究和实践。
该范围综述方案是根据 Arksey 和 O'Malley 和 Levac 制定的，并遵循系统评价和荟萃分析扩展的首选报告项目（PRISMA）扩展的范围综述指南。我们将在 Scopus、PubMed、Medline Ovid、Cochrane 和 Web of Science 数据库中搜索 2011 年 1 月至 2021 年 7 月期间发表的关于 HPVSS 使用和可接受性的证据。我们还将搜索以论文/论文、会议记录、世卫组织等国际组织的网站以及相关政府报告等形式的灰色文献，这些文献报告了撒哈拉以南非洲女性 HPVSS 筛查 CC 计划的证据。
由于该研究不包括动物或人类参与者，因此不需要进行伦理审查。拟议的范围综述的结果将以同行评议的期刊、印刷品和会议演示的形式在电子方式上传播。
